RxDoctor Payments DataLook up a doctor →

Vijay Iyer, MD

Cardiovascular Disease · Amherst, NYNPI 1114947272

Payments from drug & device makers

$4,313,840in general payments, 2019–2025

Across 3,374 payments — averaging $1278.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2.3M
  • Boston Scientific$939K
  • Abbott$497K
  • Medtronic$191K
  • W. L. Gore & Associates, Inc.$179K
  • Arrow International, Inc.$72K
  • plus $177K from 38 others
$318in research payments, 2019–2025

Across 7 payments — averaging $45.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$318

What the payments were for

  • Consulting fees$375,85644%
  • Speaking & faculty fees$304,33636%
  • Grants$550%
  • Travel & lodging$113,86513%
  • Food & beverage$60,4367%
  • Education$690%
  • Entertainment$1800%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences1,619$2,258,737
Boston Scientific500$939,384
Abbott424$496,967
Medtronic(2 entities)268$191,368
W. L. Gore & Associates, Inc.76$178,788
Arrow International, Inc.16$72,068
Janssen Research & Development, LLC25$47,856
Essential Medical, Inc.8$45,594
Magenta Medical Inc1$22,080
Abiomed208$21,443
Siemens Medical Solutions USA, Inc.37$13,063
Recor Medical Inc17$11,370
Cardiva Medical, Inc.20$6,133
Opsens Inc.4$2,329
Ancora Heart, Inc.8$2,145
Philips North America LLC16$898
Pfizer20$357
AOP Health US, LLC1$312
Novartis20$284
Cardiac Dimensions, Inc.3$275
Cordis US CORP.3$224
Impulse Dynamics (USA) Inc.5$223
AstraZeneca6$219
Inari Medical, Inc.6$216
Teleflex LLC3$202
E.r. Squibb & Sons, L.L.C.27$192
Irhythm Technologies, Inc.3$189
Actelion Pharmaceuticals US, Inc.5$153
Heartflow, Inc.1$150
GE HealthCare1$125
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)5$100
Stryker2$68
Johnson & Johnson3$56
Angiodynamics, Inc.2$44
Boehringer Ingelheim2$37
Takeda Pharmaceuticals U.S.A., Inc.1$30
United Therapeutics Corporation1$27
Getinge USA Sales, LLC1$27
Alnylam Pharmaceuticals Inc.1$23
Amgen1$20
Terumo Medical Corporation1$18
Lexicon Pharmaceuticals, Inc.1$17
Livanova USA, Inc.1$14
Penumbra, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,313,840 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024
$192,096
Medicare patients
316
Services billed
598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Amherst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →